Bandingkan Harga & Kinerja Sky Energy Indonesia Tbk. (JSKY) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sky Energy Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Sky Energy Indonesia Tbk. diperdagangkan di Rp52 (kapitalisasi pasar 105,69 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sky Energy Indonesia Tbk. dan Organon Pharma Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| JSKY | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 105,69 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sky Energy Indonesia Tbk.
PT Sky Energy Indonesia (the Entity) was established based on Notarial Deed No. 6, dated July 4, 2008 of Petrus Suandi Halim, S.H., notary in Jakarta. Initially the Entity engaged as distributor of solar modules and provider of System Integration technical services for the manufacture of Pembangkit Listrik Tenaga Surya (PLTS) On-grid and Off-grid types, including technical design, installation and maintenance. in 2009 the Entity cooperated with PT Hitachi High-Technologies Indonesia to establish an international-class solar module manufacturing facility. In the year of 2012, the Entity commenced the production of solar modules with a capacity of 10 MW. By 2016, The Entity has grown to become the largest producer of solar modules in Indonesia with capacity production of 100 MW for solar modules and 50 MW for solar cells.
Selengkapnya di halaman JSKY →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
